Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
about
Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma.Platelet-to-lymphocyte ratio predicts the prognosis of patients with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy.Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis
P2860
Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Preoperative platelet-to-lymph ...... oing curative liver resection.
@en
Preoperative platelet-to-lymph ...... oing curative liver resection.
@nl
type
label
Preoperative platelet-to-lymph ...... oing curative liver resection.
@en
Preoperative platelet-to-lymph ...... oing curative liver resection.
@nl
prefLabel
Preoperative platelet-to-lymph ...... oing curative liver resection.
@en
Preoperative platelet-to-lymph ...... oing curative liver resection.
@nl
P2093
P2860
P356
P1433
P1476
Preoperative platelet-to-lymph ...... oing curative liver resection.
@en
P2093
Bang-De Xiang
Cheng-Mao Zhou
Hao-Jie Yang
Jing-Hang Jiang
Neng-Zhi Chen
Qing-An Liu
Yang-Feng Du
P2860
P304
1010428317707375
P356
10.1177/1010428317707375
P577
2017-06-01T00:00:00Z